Proteome-wide Mendelian randomization identifies therapeutic targets for asthma
International Journal of Health Sciences · 2026
DOI: 10.25259/ijhs_215_2025 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Health Sciences, 2026. Verfasst von Yuhui Yan und 1 weiteren Autor:innen. Die Arbeit nennt 38 Literaturangaben.
Abstract (Originalsprache)
Objectives
Asthma is a prevalent chronic inflammatory disease that involves a complex interaction between various cells of the innate and adaptive immune systems and epithelial cells. Anti-inflammatory therapeutic approaches have proven superior in controlling asthma and reducing exacerbation rates and are receiving increasing attention. The treatment of asthma is a potentially actionable target pending further validation. This study presented integrative evidence that supports both previously reported and emerging causal proteins, as well as potential drug targets, for asthma.
Methods
Mendelian randomization (MR) analysis, colocalization (COLOC) analysis, phenome-wide association (PWAS) analysis, transcriptome analysis, single-cell data analysis, protein–protein interaction medication targets analysis.
Results
Nephronectin (NPNT) and neuronal growth regulator 1 (NEGR1) were found to be statistically significantly associated with a noticeable protective effect against asthma, tumor necrosis factor, alpha-induced protein 3 (TNFAIP3) showed a suggestive statistical association with a protective effect against asthma in MR analyses. COLOC indicated that NPNT and NEGR1 have greater potential as drug targets. Compared with normal tissues, NPNT exhibited a higher expression level in Type II pneumocytes; NEGR1 was upregulated in smooth muscle cells, regulatory T cells, plasmacytoid dendritic cells, helper T cells; TNFAIP3 expression was decreased in Cluster of differentiation 4 (CD4)-positive alpha-beta T cells, lung ciliated cell 1, smooth muscle cells, whereas it was elevated in CD8-positive alpha-beta T cell 1, helper T cells, and myelocytes in asthma lung tissues. The interaction between Integrin alpha-8 (ITGA8) and NPNT, as well as the interaction between melanocortin-4 receptor and NEGR1, might serve as potential therapeutic targets.
Conclusion
NPNT and NEGR1 could be promising targets for current asthma medications. NEGR1 was first identified in MR of asthma, and we further performed across-omics validation to verify the roles of NPNT, NEGR1, and TNFAIP3.
Zitieren
APA
Yan, Y., & Chen, X. (2026). Proteome-wide Mendelian randomization identifies therapeutic targets for asthma. International Journal of Health Sciences. https://doi.org/10.25259/ijhs_215_2025
Vancouver
Yan Y, Chen X. Proteome-wide Mendelian randomization identifies therapeutic targets for asthma. International Journal of Health Sciences. 2026. doi:10.25259/ijhs_215_2025
BibTeX
@article{Yan2026,
author = {Yan, Yuhui and Chen, Xiaohua},
title = {Proteome-wide Mendelian randomization identifies therapeutic targets for asthma},
journal = {International Journal of Health Sciences},
year = {2026},
doi = {10.25259/ijhs_215_2025}
}
EUVIMED